Image de couverture de livre

Cardiovascular risk and triptan usage among patients with migraine

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Ido Peles, Ruth Smadar Shneyour, Eran Levanon, Yana Mechnik Steen, Ibraheem Abu Salameh, Michal Gordon, Ran Abuhasira, Victor Novack, Gal Ifergane
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Headache: The Journal of Head and Face Pain
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Response to “Optimizing triptan safety in emergency settings under cardiovascular risk uncertainty”
par: Ido Peles, et autres
Publié: (2025)

Optimizing triptan safety in emergency settings under cardiovascular risk uncertainty
par: Yalcin Golcuk
Publié: (2025)

Do patients with migraine and obesity receive different treatments? Insights from real‐world data
par: Keshet Pardo, et autres
Publié: (2025)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
par: Graham A. McLeod, et autres
Publié: (2025)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
par: Rikki Mangrum, et autres
Publié: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
par: Yunus Emre Meydanal, et autres
Publié: (2025)

Evaluating associations of migraine‐related vertigo
par: Nazia Karsan, et autres
Publié: (2025)

Afterimage duration differs for migraine with or without aura
par: Florian Rimmele, et autres
Publié: (2025)

Mechanisms for mindfulness in migraine: Does catastrophizing matter?
par: Rebecca Erwin Wells, et autres
Publié: (2024)

Useful considerations for treating migraine in patients with autism
par: Sinifunanya E. Nwaobi
Publié: (2026)

Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
par: Gabriel Camargo de Oliveira, et autres
Publié: (2026)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
par: Shuu‐Jiun Wang, et autres
Publié: (2024)

No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
par: Inga Zalia Tummoszeit, et autres
Publié: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
par: Chia‐Chun Chiang, et autres
Publié: (2024)

Counting the cost: How migraine shapes lives and economies
par: Risako Shirane, et autres
Publié: (2025)

Depression and anxiety are not associated with migraine outcomes in children and adolescents
par: Amy A. Gelfand
Publié: (2024)

Cognitive and emotional mechanisms underlying migraine quality of life
par: Shiri Shinan‐Altman, et autres
Publié: (2026)

Integrating gepants into clinical practice for the acute treatment of migraine
par: Richard B. Lipton, et autres
Publié: (2026)

A retrospective analysis of the use of candesartan for migraine prevention in adolescents
par: Irene Patniyot, et autres
Publié: (2024)

Chronotype in migraine and tension‐type headache: A population study
par: Da Eun Jung, et autres
Publié: (2026)

Magnetoencephalography studies in migraine and headache disorders: A systematic review
par: Raghavan Gopalakrishnan, et autres
Publié: (2024)

Causal associations between genetically predicted placental weight and migraine
par: Chung‐Chih Liao, et autres
Publié: (2025)

Time to reconsider the association between migraine and white matter hyperintensities?
par: Anders Hougaard
Publié: (2025)

Investigating the causal and genetic relationship between migraine and Parkinson's disease
par: Ming‐Gang Deng, et autres
Publié: (2024)

Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents
par: Bilal Ahmed Rizvi, et autres
Publié: (2024)

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
par: Susan Hutchinson, et autres
Publié: (2026)

The role of stress in the comorbidity of migraine and other chronic primary pain
par: Shi‐Jie Zhao, et autres
Publié: (2025)

Beyond symptom: Exploring the analgesic properties of vomiting in patients with migraine
par: Antonio Munafò, et autres
Publié: (2026)

Prevalence and burden of migraine in the United States: A systematic review
par: Fred Cohen, et autres
Publié: (2024)

The “central vein sign” to differentiate multiple sclerosis from migraine
par: Giulia Silvestri, et autres
Publié: (2025)

Microneedles for the treatment of migraine and orofacial pain: A narrative review
par: Baicheng Cao, et autres
Publié: (2026)

The association between posttraumatic stress disorder and migraine: A systematic review
par: Lucie Nitsche, et autres
Publié: (2026)

Long‐term evolution of white and gray matter structural properties in migraine
par: Álvaro Planchuelo‐Gómez, et autres
Publié: (2025)

Effectiveness and acceptability of oral migraine preventives: A prospective, observational study
par: Hedda S. Riise, et autres
Publié: (2026)

Evidence for increased background neural noise in migraine with aura: Hyperactive but not hyperresponsive
par: Louise O'Hare, et autres
Publié: (2025)

Delayed urticaria during treatment with anti‐ CGRP monoclonal antibodies in migraine
par: Christoph T. Berger, et autres
Publié: (2026)

Genetically proxied liability to migraine and risk of intracranial aneurysm and subarachnoid hemorrhage
par: Iyas Daghlas, et autres
Publié: (2024)

Behavioral interventions for migraine prevention: A systematic review and meta‐analysis
par: Jonathan R. Treadwell, et autres
Publié: (2025)

Flexible modeling of headache frequency fluctuations in migraine with hidden Markov models
par: Gina M. Dumkrieger, et autres
Publié: (2024)

Memantine as a migraine prophylactic agent in adolescents: A retrospective analysis
par: M. Ismail K. Yousaf, et autres
Publié: (2025)